CMS: Medicare Program; Inflation Reduction Act of 2022 (IRA) Medicare Drug Price Negotiation Program Draft Guidance; Comment Request

Federal Register

Jul 20, 2026

Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on draft guidance for the Medicare Drug Price Negotiation Program regarding manufacturer effectuation of the maximum fair price in 2028 for the implementation of the Inflation Reduction Act of 2022 (IRA). Comments are due by September 18, 2026.

Healthcare business and finance · Legislation and regulations · Pharmacy and prescription drugs